Company intelligence / Profile preview

Voyant Diagnostics

Skokie, Illinois, United Statesmedstartr.com ↗

Ownership: Private
Development stage: Other

Overview

Voyant Diagnostics has developed a smart toilet platform that fully automates point-of-care urine testing. The system is designed to expedite turnaround times in high-volume healthcare settings such as emergency departments, aiming to increase patient throughput and capacity while reducing user error. A feasibility clinical trial was launched in 2018 for an automated point-of-care urine diagnostic device focused on pregnancy diagnosis[4][5].

Therapeutic areas: Women's Health
Modalities: Device (Automated point-of-care diagnostic platform)Non-pharmacological therapy (diagnostic)
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Voyant Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voyant Diagnostics.

Explore the full profile